Federal contract award
75N98023P02336
NATL DISEASE RESCH INTERCHANGE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH OLAO |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $10.0K |
| Current contract value | $10.0K |
| Potential contract value / ceiling | $10.0K |
| Start date | Jul 7, 2023 |
| Current end date | Jul 7, 2024 |
| Potential end date | Jul 7, 2024 |
| Latest award activity | Aug 26, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 26, 2026 | P00001 | $-260 | FY 26 UDO INITIATIVE NATL DISEASE RESCH INTERCHANGE |
| Jul 7, 2023 | 0 | $10.3K | NATL DISEASE RESCH INTERCHANGE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.